Optimizing Hydroxyurea use in children with sickle cell disease: low dose regimen is effective-Reference-Cited by-同舟云学术

Optimizing Hydroxyurea use in children with sickle cell disease: low dose regimen is effective

Published:2013-04-20 Issue:6 Volume:90 Page:519-524
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur J Haematol

Author:

Sharef Sharef Waadallah¹,Al-Hajri Maya¹,Beshlawi Ismail¹,Al-Shahrabally Aamir¹,Elshinawy Mohamed¹,Zachariah Mathew¹,Mevada Surekha Tony¹,Bashir Wafaa¹,Rawas Abdulhakim¹,Taqi Aqeela²,Al-Lamki Zakiya¹,Wali Yasser¹

Affiliation:

1. Department of Child Health; Sultan Qaboos University Hospital; Muscat; Oman

2. Department of Pharmacy; Sultan Qaboos University Hospital; Muscat; Oman

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ejh.12103/fullpdf

Reference21 articles.

1. Public health implications of sickle cell trait: a report of the CDC meeting;Grant;Am J Prev Med,2011

2. Haemoglobinopathies encountered at Khoula Hospital, Oman;Adly;Sultan Qaboos Univ Med J,2008

3. Advances in clinical research in sickle cell disease;Hagar;Br J Haematol,2008

4. Decreased sickle red blood cell adhesion to laminin by hydroxyurea is associated with inhibition of Lu/BCAM protein phosphorylation;Bartolucci;Blood,2010

5. Cellular effects of hydroxyurea in Hb SC disease;Steinberg;Br J Haematol,1997

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of Hydroxyurea Therapy on Growth Parameters in Older Children (6-15 Year-Old) with Sickle Cell Disease: Low Dose Versus High Dose;Hemoglobin;2023-07-04

2. Impact of Hydroxyurea Starting Dose on Pain Outcomes in Patients with Sickle Cell Disease;Journal of Pain & Palliative Care Pharmacotherapy;2022-10-02

3. Hydroxyurea Use Among Children With Sickle Cell Disease at King Abdulaziz University Hospital in Jeddah City;Cureus;2021-02-20

4. The role of hydroxyurea in decreasing the occurrence of vasso-occulusive crisis in pediatric patients with sickle cell disease at King Saud Medical City in Riyadh, Saudi Arabia;Saudi Medical Journal;2020-01

5. Rational Drug Design of Peptide-Based Therapies for Sickle Cell Disease;Molecules;2019-12-12